Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.

Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma. Mol Cancer Res. 2012 Jun; 10(6):800-9.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.